Kalbitor

Active Ingredient(s): Ecallantide
FDA Approved: * November 27, 2009
Pharm Company: * DYAX CORP.

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Kalbitor Overview

Ecallantide (trade name Kalbitor) is a drug used for the treatment of hereditary angioedema (HAE) and in the prevention of blood loss in cardiothoracic surgery.[1] It is an inhibitor of the protein kallikrein and a 60-amino acid polypeptide which was developed from a Kunitz domain through phage display to mimic antibodies inhibiting kallikrein.[1] Contents 1 Medical uses 1.1 Angioedema 2 Adverse effects 3 Interactions 4 Mechanism of action 5 See also 6 Ref...

Read more Kalbitor Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ecallantide

Recent Kalbitor Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Kalbitor: (2 results)

Sorted by National Drug Code

• 47783-101 Kalbitor 10 mg/ml Subcutaneous Injection, Solution by Dyax Corp.
• 65044-7611 Kalbitor 10 mg/ml Subcutaneous Injection, Solution by Jubilant Hollisterstier LLC

Other drugs which contain Ecallantide or a similar ingredient: (1 result)

• ECALLANTIDE